Kolexia
Veyrard Pauline
Gastro-entérologie
Clinique Mutualiste Mfl Ssam
Saint-Étienne, France
53 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies inflammatoires intestinales Rectocolite hémorragique Colite Maladie de Crohn Ulcère Nécrose Inflammation Syndrome du côlon irritable Syndrome des cassures de Nijmegen

Industries

Abbvie
27 collaboration(s)
Dernière en 2023
Janssen
7 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023
Amgen
4 collaboration(s)
Dernière en 2023

Dernières activités

VIRCH: Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up
Essai Clinique (CHU Saint-Étienne)   14 novembre 2023
CYTOVEDO: Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.
Essai Clinique (CHU Saint-Étienne)   06 juin 2023
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease.
Journal of Crohn's & colitis   21 avril 2023
RECOHFERRON: Place of the QuantiFERON-CMV (QF-CMV) Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (UC)
Essai Clinique (CHU Saint-Étienne)   14 avril 2023
P682 Development of anti-ustekinumab antibodies is an independent factor associated to loss of response to ustekinumab therapy in IBD patients
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
Inflammatory bowel diseases   09 mai 2022
Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis: Combination Corticosteroids + 5-aminosalicylic Acids Compared to Corticosteroids Alone in the Treatment of Moderate-severe Active Ulcerative Colitis.
Essai Clinique (Sheba Medical Center)   06 mai 2022
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   17 mars 2022
Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   08 mars 2022
Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's disease.
Alimentary pharmacology & therapeutics   28 février 2022